نتایج جستجو برای: gestational trophoblastic disease gtd

تعداد نتایج: 1520535  

Journal: :Urology journal 2005
Alireza Kheradmand

Gestational trophoblastic diseases (GTDs) are disorders with abnormal growth of the placenta. They are always associated with a conception.(1) Choriocarcinoma that is a malignant type of GTD, can spread virtually anywhere in the body through hematogenous or lymphatic route, but it most commonly spreads to lung, lower genital tract (cervix, vagina, and vulva), brain, and liver.(2) We report a ca...

2015
Teresa Liliana Wargasetia Nurhalim Shahib Djamhoer Martaadisoebrata Diah Dhianawaty Bethy Hernowo

BACKGROUND The pathogenesis of Gestational Trophoblastic Disease (GTD) is not clearly known. OBJECTIVE In this study, immunoexpression of proteins Bcl-2 and Beclin-1 in trophoblastic lesions and normal trophoblastic tissue was conducted to study the mechanism of apoptotic and autophagic cell death that is expected to complete the study of GTD pathogenesis. MATERIALS AND METHODS Bcl-2 and Be...

2018
Reham M. Balahmar David J. Boocock Clare Coveney Sankalita Ray Jayakumar Vadakekolathu Tarik Regad Selman Ali Shiva Sivasubramaniam

Treatment of gestational trophoblastic diseases (GTD) involves surgery, radiotherapy and chemotherapy. Although, these therapeutic approaches are highly successful, drug resistance and toxicity remain a concern for high risk patients. This Chemoresistance has also been observed in the presence of cancer stem cells that are thought to be responsible for cases of cancer recurrence. In this study,...

عرفانی, نصراله, نعیمی, سیروس,

  Background and Aim: Gestational trophoblastic disease (GTD) is one of complications of pregnancy and has different subtypes (complete mole, partial mole and choriocarcinoma). Macrophage derived factor or CCL22 is a member of chemokines that produced by macrophages, dendritic cells and tumors cells. It has an important role in the recruitment of T regulatory cells and T helper2 lymphocytes to ...

2017
Kathryn McGregor Aung Myat Min Noaeni Karunkonkowit Suporn Keereechareon Mary Ellen Tyrosvoutis Nay Win Tun Marcus J Rijken Gabie Hoogenboom Machteld Boel Kesinee Chotivanich François Nosten Rose McGready

BACKGROUND The use of obstetric ultrasound in the diagnosis of gestational trophoblastic disease (GTD) in high-income settings is well established, leading to prompt management and high survival rates. Evidence from low-income settings suggests ultrasound is essential in identifying complicated pregnancies, but with limited studies reviewing specific conditions including GTD. OBJECTIVE The ai...

Journal: :Human reproduction update 2011
Ewka C M Nelissen Aafke P A van Montfoort John C M Dumoulin Johannes L H Evers

BACKGROUND The placenta is of utmost importance for intrauterine fetal development and growth. Deregulation of placentation can lead to adverse outcomes for both mother and fetus, e.g. gestational trophoblastic disease (GTD), pre-eclampsia and fetal growth retardation. A significant factor in placental development and function is epigenetic regulation. METHODS This review summarizes the curre...

Journal: :International journal of cancer management 2022

Introduction: Gestational trophoblastic disease (GTD) includes hydatiform mole, choriocarcinoma, placental site tumor, and epithelial tumor. Also, molar pregnancy can happen as an ectopic pregnancy. The coincidence of these complicated pregnancies seems to occur extremely rarely. Case presentation: Here, we presented a 26-year-old woman, nulli gravida with the first presentation intrauterine co...

شرافتی, گلرخ , فانی, آذر , یوسفی, زهره ,

Background: Standard treatment of Gestational Trophoblastic Disease (GTD) is chemotherapy. Single-agent chemotherapy regime including Methotrexate (MTX) or Actinomycin. Single-agent is widely used in treatment of persistent trophoblastic disease. We reported an uncommon toxicity of low-dose single-agent methotrexate in a patient. Case Presentation: A 20-year-old woman, primary gravid after two ...

Journal: :Asian Pacific journal of cancer prevention : APJCP 2015
Varangkana Wairachpanich Sompop Limpongsanurak Ruangsak Lertkhachonsuk

BACKGROUND The incidence of hydatidiform mole (HM) differs among regions but has declined significantly over time. In Thailand, the initiation of universal health coverage in 2002 has resulted in a change of medical services countrywide. However, impacts of these policies on gestational trophoblastic disease (GTD) cases in Thailand have not been reported. This study aimed to find the incidence ...

Journal: :American journal of obstetrics and gynecology 2010
John R Lurain

Gestational trophoblastic disease includes hydatidiform mole (complete and partial) and gestational trophoblastic neoplasia (invasive mole, choriocarcinoma, placental site trophoblastic tumor, and epithelioid trophoblastic tumor). The epidemiology, pathology, clinical presentation, and diagnosis of each of these trophoblastic disease variants are discussed. Particular emphasis is given to manag...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید